Investigational 13-valent Pneumococcal Polysaccharide Conjugate Vaccine
PRO-PCV-1001
Phase 1 mab completed
Quick answer
Investigational 13-valent Pneumococcal Polysaccharide Conjugate Vaccine for Pneumococcal Infections is a Phase 1 program (mab) at SINOVAC BIOTECH LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- SINOVAC BIOTECH LTD
- Indication
- Pneumococcal Infections
- Phase
- Phase 1
- Modality
- mab
- Status
- completed